Mississippi Medical Marijuana Program

This page has been automatically translated from English. MSDH has not reviewed this translation and is not responsible for any inaccuracies.

The Mississippi State Department of Health is now in the planning stages of the many elements needed to implement a successful medical marijuana program for the state.

MSDH is currently working to establish production, regulation and licensing structures in time for the target date of August 15, 2021. Initiative 65 requires that regulations for all aspects of the program, including production and licensing for sale, must be in place by July 1, 2021.

The Mississippi State Department of Health (MSDH) continues to warn Mississippians to be aware of companies promoting pre-registration and telemedicine consultations for medical marijuana cards. MSDH is in charge of implementing a medical marijuana program, and has not released any regulations or licensed any providers at this time. Therefore, it is premature for any company or entity to post information or offer services regarding medical marijuana. Do not be vulnerable to these scams. You should always refer to this web page for the latest information.

Laboratory Requirements for Public Comment

Product Safety/Laboratory Requirements have been filed with the Mississippi Secretary of State's Office for public comment.

Comments: Comments can be sent to MedicalMarijuana@msdh.ms.gov with Lab Public Comment in the subject line of the email.

Oral proceeding

An public oral proceeding has been scheduled for May 11, 2021 at 10:30 a.m.

Provisional Timeline

MSDH is currently working toward developing regulations according to the following estimated timeline:

Estimated dateRegulatory action
Monday, April 19File draft rules with the Mississippi Secretary of State
Tuesday, April 20First public comment period begins
Tuesday, May 11Oral proceedings
Saturday, May 15First public comment period ends
Friday, May 21Board reviews public comments and makes recommendations for changes
Friday, May 28Board to adopt changes
Monday, June 1Refile changes for second public comment period
Tuesday, June 2 – 
Sunday, June 27
Second public comment period
Tuesday, June 29Final Board review
Wednesday, June 30Filing of final rules, effective July 1

Qualifying Conditions

Debilitating medical conditions under Initiative 65:

  • Acquired Immune Deficiency Syndrome
  • Agitation of dementias
  • Amyotrophic lateral sclerosis
  • Autism with aggressive or self-injurious behaviors
  • Cachexia
  • Cancer
  • Chronic or debilitating pain
  • Crohn's disease
  • Epilepsy, or other seizures
  • Glaucoma
  • Huntington's disease
  • Intractable nausea
  • Multiple Sclerosis
  • Muscular Dystrophy
  • Pain refractory to appropriate opioid management
  • Parkinson's disease
  • Positive status for Human Immunodeficiency virus
  • Post-Traumatic Stress Disorder
  • Severe muscle spasticity
  • Sickle-cell Anemia
  • Spinal cord disease or severe injury
  • Ulcerative Colitis

Or another medical condition of the same kind or class as those enumerated and for which a physician believes the benefits of using medical marijuana would reasonably outweigh potential health risks.


A licensing system has not yet been established, and we cannot currently accept requests for licenses. Look for licensing requirements and other details as they are developed. However, if a company plans to apply for licensure through the Mississippi State Department of Health for any aspect of the Medical Marijuana Program, potential applicants can take steps now.

Business registration with the Mississippi Secretary of State is anticipated to be a licensure requirement for participation in the Medical Marijuana Program. When forming a Mississippi company, or registering your foreign company to do business in Mississippi, potential applicants should register with the Mississippi Secretary of State's Office. As a part of this registration, entities are required to select an NAICS Code as part of the formation or registration. If the company is interested in being licensed as a part of the Medical Marijuana Program, the applicable NAICS Codes are 111419, 424590, 453998, and 111998. Applicants should choose from one of those available codes in order to complete formation/registration of their business in Mississippi.


The Mississippi State Board of Health and the Medical Marijuana Advisory Committee regularly hold online meetings to discuss progress on the state's medical marijuana program. Videos of past meetings are below.

Advisory Committee


  • Dr. Thomas Dobbs
    State Health Officer, Mississippi State Department of Health
  • Sean Tindell
    Commissioner, Mississippi Department of Public Safety
  • Wendy Bailey
    Executive Director, Mississippi Department of Mental Health
  • Chris Graham
    Commissioner, Mississippi Department of Revenue
  • Andy Gipson
    Commissioner, Mississippi Department of Agriculture
  • Dr. Claude Brunson
    Executive Director, State Medical Association
  • Dr. Kenneth Cleveland
    Executive Director, Mississippi Board of Medical Licensure
  • Susan McCoy
    Executive Director, Mississippi Board of Pharmacy
  • Liz Welch
    Executive Director, Mississippi Department of Finance and Administration
  • Michael Watson
    Mississippi Secretary of State
  • Dr. Larry Walker
    Director Emeritus, National Center for Natural Products Research, University of Mississippi
  • Dr. Thomas Hudson
    President, Jackson State University

For inquiries about Mississippi's developing medical marijuana program, send e-mail to MedicalMarijuana@msdh.ms.gov

Get COVID-19 e-mail updates daily with our free newsletter: 
Last reviewed on Nov 6, 2020
Mississippi State Department of Health 570 East Woodrow Wilson Dr Jackson, MS 39216 866-HLTHY4U Contact and information

Facebook Twitter Instagram RSS

Accredited by the national Public Health Accreditation Board